Real-World Safety and Clinical Outcomes of Macitentan in Asian Patients with Pulmonary Arterial Hypertension: A Prospective Multicenter Study.

Su Young JungSung-A ChangJong-Min SongJae Young ChoiHyung-Kwan KimJung Hyun ChoiJung Yeon ChinMinseok ParkSuYoun KimSeo Young Song

Published in: Drugs - real world outcomes (2022)

This real-world study demonstrated the safety and clinical outcomes of macitentan use in Korean patients with pulmonary arterial hypertension. Macitentan was well tolerated and significantly effective with no new safety concerns during the 24 weeks.

Keyphrases

pulmonary arterial hypertension
pulmonary artery
pulmonary hypertension
preterm birth
gestational age